California Court Fines Cannabis Businesses $128 Million for Illegal Operations

Dec.08.2022
California Court Fines Cannabis Businesses $128 Million for Illegal Operations
Four marijuana businesses and three individuals were fined $128 million for illegal operations in Southern California.

Four marijuana businesses and three individual owners in Southern California were fined $128 million on December 5th after admitting to operating illegally in court, according to a summary judgment ruling.


Judge Stephen Pfahler of the Los Angeles County Superior Court has made a ruling based on an investigation conducted by California authorities in 2019 and 2020 at Kanoga Park in California. The defendant admitted to engaging in unlicensed commercial manufacturing and distribution of marijuana in 527 separate locations.


In particular, a survey revealed that unauthorized activities were related to Vertical Bliss Inc., one of four entities named, according to the California Bureau of Cannabis Control, which had a commercial cannabis manufacturing and distribution license in the state at the time.


In July 2021, the DCC, formerly a state agency, was established by merging three previous organizations. Following an investigation in November 2019, Vertical Bliss' license was swiftly revoked. At that time, the state's Bureau of Cannabis Control and the Department of Public Health conducted a search of an unlicensed facility in Canoga Park, seizing illegal products worth $21 million, including 7,200 vaping pods.


In September 2020, the agency and CDPH filed a lawsuit seeking civil penalties against Vertical Bliss. At the time of filing, state regulators also announced that seized records allegedly showed Vertical Bliss produced over 3.3 million Kushy Punch Inc. brand products in 18 months, estimated to be worth $64 million.


After the defendant failed to appear in court for the second time, Pfahler issued a civil penalty order this week.


This ruling sends a strong message that California will not tolerate the illegal marijuana market," stated Nicole Elliott, Director of the Department of Cannabis Control (DCC), in a press release. "The DCC and our partners will work tirelessly to protect consumers and maintain the integrity of California's legal marijuana market. We commend the court for upholding the rule of law in the California cannabis industry.


Apart from Vertical Bliss and Kushy Punch Inc., Conglomerate Marketing LLC and More Agency Inc. have been named as corporate defendants in this case. They have each admitted to earning over $10 million and $1 million respectively annually from unlicensed commercial marijuana manufacturing and distribution.


As for the individual defendants, each of them engaged in illegal commercial marijuana activities through their recognized ownership, ownership interests, control, and management of the commercial entities being charged," stated the order.


The fine of $128 million was calculated by multiplying a licensing fee of $81,000 by 527, as outlined by the state's commercial and occupational codes, for each day of violation. These regulations state that individuals engaging in unlicensed marijuana activity "shall be subject to a civil fine of up to three times the amount of the licensing fee for each violation.


According to a statement released by the department, DCC officials are continuing to seek "a fair and appropriate resolution for one remaining defendant" in addition to the seven defendants included in Pfahler's ruling.


According to a summary by Pfahler, the fourth individual defendant failed to appear in court on December 5th and the final verdict for the case will be announced on January 5, 2023, at the Chatsworth Court in the civil department.


2FIRSTS will continue to track and report on this topic, with updates available on the 2FIRSTS APP. Scan the QR code below to download the app.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Trump Picks White House Health Policy Aide Heidi Overton to Lead FDA, Pending Senate Confirmation
Trump Picks White House Health Policy Aide Heidi Overton to Lead FDA, Pending Senate Confirmation
U.S. President Donald Trump has chosen White House health policy aide Heidi Overton to lead the Food and Drug Administration, Bloomberg reported, citing a person familiar with the matter. Overton currently works on health policy at the White House and previously held a senior role at the America First Policy Institute. If confirmed by the Senate, she would take over an FDA that has experienced months of senior-level turnover. The agency regulates products representing roughly one-fifth of U.S. consumer spending, including e-cigarettes, drugs, vaccines and much of the food supply.
News
Aug.19
Earnings Analysis | CTIHK H1 2026 Revenue Falls 26.9% as Core Businesses Diverge and New Growth Drivers Remain to Be Proven
Earnings Analysis | CTIHK H1 2026 Revenue Falls 26.9% as Core Businesses Diverge and New Growth Drivers Remain to Be Proven
China Tobacco International (HK) reported a 26.9% revenue decline in H1 2026, while gross profit fell only 9.5%, revealing sharp divergence across its businesses. Tobacco leaf imports contracted, while leaf exports and Brazil operations expanded strongly. Cigarette exports faced China duty-free market transition, and new tobacco products remained small. Meanwhile, CTIHK continues to strengthen its role as an investment and financing platform, though major external deals have yet to emerge. 2Firsts examines what these shifts mean for its next growth drivers.
Capital Markets
Aug.24
Australian Coalition Unveils Illicit Tobacco Plan With 80% Excise Cut and Legal, Taxed Vapes and Nicotine Pouches
Australian Coalition Unveils Illicit Tobacco Plan With 80% Excise Cut and Legal, Taxed Vapes and Nicotine Pouches
Australia’s Coalition has unveiled a national illicit-tobacco policy that would cut tobacco excise by 80% and create legal, regulated and taxed adult markets for vaping products and nicotine pouches if it wins government. The plan proposes an excise of A$0.50 per millilitre of e-liquid and A$0.025 per milligram of nicotine in pouches, alongside A$200 million in additional enforcement and a A$60 million three-year public-awareness campaign. The Coalition says the package would narrow the price advantage of illicit products and undermine organised crime, while Labor and public-health groups warn that dramatically cheaper cigarettes could reverse long-term declines in smoking.
Sep.03
China Tobacco Hubei explores staged nicotine pouch delivery, using dynamic membranes to slow early release and gradient particles to sustain later delivery
China Tobacco Hubei explores staged nicotine pouch delivery, using dynamic membranes to slow early release and gradient particles to sustain later delivery
China Tobacco Hubei Industrial Co., Ltd. disclosed several oral nicotine-related patent applications in August 2026, including two that approach staged nicotine release from different directions. One uses a high-viscosity membrane that forms inside the pouch after contact with saliva to slow rapid early release, while the other uses gradient particles with a faster-disintegrating outer layer and a slower core to create a fast-to-sustained release profile. Together, the filings explore how nicotine pouches could balance initial delivery with release later in use.
Sep.03
Special Report|AIR H1 Revenue Rises 3.7% as Shisha Volumes Fall 9%, Testing Its Shift Beyond Traditional Hookah
Special Report|AIR H1 Revenue Rises 3.7% as Shisha Volumes Fall 9%, Testing Its Shift Beyond Traditional Hookah
AIR’s first half-year results as a listed company offer a new test of how far a traditional hookah business can transform. H1 2026 revenue rose 3.7%, even as Flavored Shisha Molasses shipments fell 9%, with pricing and mix supporting growth. Traditional shisha still generates almost all revenue, while OOKA, Crown Switch, Greentank and U.S. regulatory spending point to accelerating diversification. The next test is whether those investments can become a second business of meaningful scale and profitability.
Capital Markets
Aug.21
Special Report | Altria Subsidiaries Sue FDA to Vacate 2021 PMTA Rule as Agency Moves to Speed Reviews
Special Report | Altria Subsidiaries Sue FDA to Vacate 2021 PMTA Rule as Agency Moves to Speed Reviews
2Firsts reviewed the original federal court complaint filed by Altria subsidiaries Helix Innovations and NJOY on Sept. 2 challenging FDA’s 2021 PMTA rule. The lawsuit questions whether FDA’s review process complies with the Tobacco Control Act’s 180-day timeline, even as the agency moves to accelerate PMTA reviews and issues more marketing orders. Drawing on the complaint, FDA records, government audits and recent court rulings, 2Firsts examines the legal arguments, supporting evidence and potential implications for the U.S. tobacco review system.
Regulations
Sep.03